Perrigo Multiple Acquisitions Expected In Next 12 Months - CEO Gibbons
This article was originally published in The Tan Sheet
Perrigo is eyeing possible near-term acquisition candidates in three main areas - global operations, nutritionals and new delivery vehicles - as the private labeler comes closer to putting its recent operational woes behind it.
You may also be interested in...
NBTY's vertical integration, international presence and acquisition history positions the supplement supplier/retailer as the leading challenger to Royal Numico, gaining the admiration of investors in the first quarter of 2001.
Corrective actions taken in response to an unfavorable FDA inspection of Perrigo's Allegan, Mich. facility will preclude the planned November launch of minoxidil 5% and stall the company's pipeline, Perrigo told analysts in an Oct. 25 conference call.
Perrigo has postponed its plans to market private label extended-release acetaminophen until it can resolve quality control issues outlined in a recent FDA warning letter.